The Sturge-weber syndrome market Players and analysis by type, diagnosis treatment, end user- forecast till 2030. Sturge-Weber syndrome is a neurological disorder characterized by a distinctive port-wine stain (PWS) on the forehead, or scalp. PWS is a birthmark caused by an overabundance of blood capillaries near the surface of the skin. Sturge-Weber syndrome is also associated with eye abnormalities such as glaucoma, and neurological abnormalities.
The global Sturge-Weber syndrome market is expanding as a result of a number of factors, including technological breakthroughs, rising public awareness, increased government aid, improvements in the regulatory environment, and rising funding and reimbursement. A publicly listed firm, Centene Corporation, has established clinical guidelines for occipital nerve stimulation for headaches.
The market's expansion could be hampered, nevertheless, by difficulties in research and development, high healthcare costs, and a deficient healthcare system in low- and middle-income nations. The Epilepsy Foundation of Greater Chicago reports that the cost of surgery varies around the world and may rise over time, while the cost of VNS therapy is estimated to be around USD 20,000.
It is estimated that Sturge-Weber syndrome market is expected to grow at a healthy CAGR of 5.10% during the forecast period 2022-2030.
Some of key the players in the global Sturge-Weber syndrome market are Valeant, Allergan, Syneron Medical Ltd., Medtronic, Cutera, St Jude Medical, Inc., Pfizer, Cyberonics, Inc., ZELTIQ Aesthetics, Inc., Novartis AG, GlaxoSmithKline plc, Abbott Laboratories, Novo Nordisk, Shire, and others.
The global Sturge-Weber syndrome market is segmented on the basis of type, diagnosis, treatment, and end-user.
On the basis of the type, the market is segmented into Type 1, Type 2, and Type 3.
On the basis of the end-users, the market is segmented into hospital, clinics, diagnostic centers, and others.
On the basis of the treatment, the market is classified as medication, laser therapy, surgical procedures, and others. The medication is further segmented into antiepileptic, beta-antagonist eye drops, carbonic anhydrase inhibitors, adrenergic eye drops, miotic eye drops, and others. The surgical procedures are further segmented into focal cortical resection, hemispherectomy, corpus callosotomy, trabeculectomy, filtration surgery, cyclocryotherapy, vagal nerve stimulation (VNS), and others.
On the basis of the diagnosis, the market is classified into skull radiography, magnetic resonance imaging (MRI), computed tomography (CT) scan, and electroencephalogram (EEG).
The Americas dominate the Sturge-Weber syndrome market owing to the rising awareness among people, and high healthcare expenditure. According to the Centers for Disease Control and Prevention, the total health expenditure in the United States was reported to be USD 3.2 trillion and hospital care accounted for a share of 32.3%.
Europe holds the second position in the global Sturge-Weber syndrome market. It is expected that the support provided by the government bodies for research development and improving reimbursement policies in the healthcare is likely to drive the market of Europe region.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)